Skip to main content
Xenon Pharmaceuticals Inc. logo

Xenon Pharmaceuticals Inc. — Investor Relations & Filings

Ticker · XENE ISIN · CA98420N1050 LEI · 549300XV44Q9Z1MIPQ03 US Manufacturing
Filings indexed 746 across all filing types
Latest filing 2019-08-16 Regulatory Filings
Country CA Canada
Listing US XENE

About Xenon Pharmaceuticals Inc.

https://www.xenon-pharma.com/

Xenon Pharmaceuticals Inc. is a neuroscience-focused biopharmaceutical company dedicated to the discovery, clinical development, and commercialization of therapeutics for neurological and psychiatric disorders. The company leverages its expertise in human genetics and a deep understanding of ion channel biology to develop medicines that modulate ion channels, targeting the central and peripheral nervous systems. Its late-stage pipeline includes azetukalner, an investigational candidate being developed for the treatment of epilepsy and depression.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2019
Regulatory Filings
2019-08-16 English
Regulatory Filings 2019
Regulatory Filings Classification · 100% confidence The document is a letter addressed to the SEC requesting acceleration of effectiveness for a Registration Statement on Form S-3. It is a correspondence related to a securities registration process, not a financial report or announcement of financial results. The document length is short (1000 characters) and it is a formal regulatory communication. It does not contain financial data, management discussion, or report content. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2019-08-13 English
Regulatory Filings 2019
Regulatory Filings Classification · 90% confidence The provided document text appears to be encoded or encrypted and does not contain any readable content, keywords, regulatory headers, or references to specific report types, fiscal periods, or regulatory bodies. Without any discernible information or context, it is impossible to classify this document as any specific filing type. Given the lack of meaningful content, the appropriate classification is the fallback category, Regulatory Filings (RNS).
2019-08-12 English
S-3
Capital/Financing Update Classification · 95% confidence The document is a Form S-3 Registration Statement filed with the SEC by Xenon Pharmaceuticals Inc. It is a registration statement under the Securities Act of 1933 for the purpose of registering securities for sale to the public. The document includes details about the types of securities to be registered, the maximum offering price, and other regulatory disclosures typical of a registration statement. It is not a financial report, earnings release, or management discussion. It is a capital markets filing related to fundraising and securities issuance. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is substantial and contains detailed registration information, not just an announcement or notice, so it is not RPA or RNS. Confidence is high given the clear identification of the form and purpose.
2019-08-06 English
10-Q
Interim / Quarterly Report Q2 2019
2019-08-06 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated August 6, 2019, by Xenon Pharmaceuticals Inc. It announces the company's financial results for the three and six month periods ended June 30, 2019, via a press release attached as an exhibit. The text explicitly states that the information is furnished but not filed, and the document is short (3437 characters). This indicates it is an announcement of financial results rather than the full financial report itself. According to the rules, such a document is classified as an Earnings Release (ER) because it is the initial announcement of quarterly financial results with key highlights only, not the full interim report or detailed financial statements.
2019-08-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.